Actinium Pharmaceuticals
ATNM
$8.15
Share price
0.49%
Change (1 day)
-2.28%
Change (1 year)
Categories
Market capitalization of Actinium Pharmaceuticals (ATNM)
Market cap: $0.24 Billion
As of June 2024 Actinium Pharmaceuticals has a market cap of $0.24 Billion. This makes Actinium Pharmaceuticals the world's 6789th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Actinium Pharmaceuticals from 2011 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.24 B | 74.3% |
| 2023 | $0.13 B | -48.69% |
| 2022 | $0.27 B | 103.93% |
| 2021 | $0.13 B | -2.68% |
| 2020 | $0.13 B | 281.41% |
| 2019 | $35.85 M | -19.92% |
| 2018 | $44.77 M | -15.68% |
| 2017 | $53.1 M | 8.87% |
| 2016 | $48.77 M | -65.73% |
| 2015 | $0.14 B | -19.37% |
| 2014 | $0.17 B | 22.01% |
| 2013 | $0.14 B | 350.93% |
| 2012 | $32.08 M | 2515.02% |
| 2011 | $1.22 M |
End of Day market cap according to different sources
On May 31st, 2024 the market cap of Actinium Pharmaceuticals was reported to be:
$0.24 Billion
$0.24 Billion
$0.24 Billion
$0.24 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | $0 M | -100.00% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $2.90 B | 1,095.85% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.25 B | 5,772.36% | 🇺🇸 USA |